Elevated adenosine deaminase levels in celiac disease.

Area of Science:

• Immunology
• Gastroenterology
• Biochemistry

Background:

• Celiac disease (CD) is a chronic inflammatory small bowel disorder triggered by gluten.
• Adenosine deaminase (ADA) is an enzyme linked to purine metabolism and immune responses.
• Elevated ADA levels are observed in various inflammatory conditions, but its role in CD is unexplored.

Purpose of the Study:

• To investigate the relationship between serum ADA levels and adult celiac disease.
• To assess ADA as a potential biomarker for CD diagnosis.

Main Methods:

• Serum ADA levels were measured in 20 newly diagnosed adult CD patients and compared to healthy controls.
• Correlation analysis was performed between ADA and CD-specific antibodies (anti-gliadin, anti-endomysial).
• Receiver Operating Characteristic (ROC) curve analysis determined the optimal ADA cut-off for CD detection.

Main Results:

• Mean serum ADA levels were significantly higher in CD patients than in controls.
• ROC analysis identified an optimal ADA cut-off of 12.27 U/L with 80% sensitivity and 100% specificity for CD.
• No significant correlation was found between ADA levels and anti-gliadin or anti-endomysial antibodies.

Conclusions:

• Significantly elevated serum ADA levels in CD patients suggest its involvement in the activated T-cell response.
• ADA may function as a supportive diagnostic marker in the clinical evaluation of celiac disease.